Survival Data for Patients Younger Than 60 With Primary Myleofibrosis

Dr. Ayalew Tefferi, Professor of Hematology and Medicine at Mayo Clinic in Rochester, MN, discusses the findings of the largest ever study with the most mature data currently available of patients with primary myelofibrosis younger than 60 years.
Available at: http://tinyurl.com/cpqx32p Improvement in survival was noted in those with high- and moderate-risk disease but not in those with low-risk disease.